may be a useful model for human autosomal dominant Han:SPRD rats with PKD were provided with a solution citrate, and lower rates of renal citrate consumption, ammonia of potassium citrate/citric acid (abbreviated "KCitr") to synthesis, and ammonia excretion. Cortical P NH3 was not elevated drink, starting at one month of age, then the glomerular in cystic kidneys. Intake of Na 3 citrate/citric acid solution or K 3 filtration rate (GFR) was sustained at a normal level and citrate solution, but not ammonium citrate/citric acid solution, prevented a decline in GFR in three-month-old rats with PKD.
the kidneys showed less cystic disease when the rats were
Conclusions. Rats with PKD show abnormal renal handling three months old [7] . By contrast, littermate rats with of citrate and ammonia. Citrate salts that have an alkalinizing PKD that drank tap water had a GFR one half of normal, effect preserve GFR and extend survival. large kidney cysts, and extensive renal interstitial disease. The present study had two purposes: (1) to ascertain whether the benefits of KCitr therapy would be Autosomal dominant polycystic kidney disease sustained beyond three months, and (2) to examine the (ADPKD) is an inherited disorder that afflicts more than mechanism of this beneficial effect. 500,000 people in the United States alone and millions
To assess the effectiveness of KCitr administration more worldwide. This disease is accompanied by the forbeyond three months of age, we treated Han:SPRD rats mation and enlargement of numerous fluid-filled epithelial with KCitr for longer times in two sets of experiments. sacs (cysts) in both kidneys and eventual development First, we treated rats, starting at the age of one month, of renal failure. There is currently no specific treatment and measured renal function at six months of age. Secto halt or slow the progression of renal failure in patients ond, we treated rats from the age of one month until their with PKD [1] .
deaths to see whether this treatment prolonged survival. In 1991, Kaspareit-Rittinghausen, Deerberg, and Wcislo
To gain some insight into the mechanism of KCitr discovered a mutant strain of Sprague-Dawley rats with therapy, we examined several parameters. First, we measured blood and urine pH values to determine whether KCitr intake affected these variables. Second, we hy-effects of KCitr treatment on these parameters were also of a solution containing 3% polyfructosan (Laevosan Co., Linz, Austria), 5.5 to 11 mg/mL sodium p-aminohippurate studied. Third, since Torres et al had suggested that (PAH), 2 g/100 mL bovine serum albumin, 24 mmol/L increased ammonia levels contribute to damage in cystic NaHCO 3 , and 125 mmol/L NaCl. A femoral artery was kidneys, we determined renal cortical tissue P NH3 and cannulated for blood sampling and for measuring blood ammonia production and excretion [9, 10] . Fourth, we pressure with a transducer (Gould-Statham, Hato Rey, tested the idea that KCitr's beneficial effect is dependent Puerto Rico). The abdomen was opened via a midline on the well-known interaction between citrate and calincision. The left ureter was cannulated, and a cannula cium ions in the body [11] . Finally, we substituted ammowas inserted into the bladder to drain urine from the nium or sodium ions for potassium ions in the citrate right kidney. A number 25 needle, connected to a short solution and also gave K 3 citrate (tripotassium citrate length of Silastic tubing, was inserted into the left renal without citric acid) to determine whether the beneficial vein for blood sampling. effect of the KCitr solution was related to its potassium Renal clearance measurements were made as follows: content or to its alkalinizing effect.
About one hour after the left ureter had been cannulated, we collected two 30-minute urine samples under METHODS water-equilibrated light mineral oil. Urine volume was determined by weighing, assuming a density of one. Urine Animals and solutions pH was measured immediately at room temperature usAll experiments were conducted in accordance with ing a 9802BN micro-pH combination electrode (Orion the National Institutes of Health Guide for the Care and Research, Beverly, MA, USA). Arterial and renal venous Use of Laboratory Animals. Experiments were perblood samples (0.60 to 0.85 mL) were collected at the formed on heterozygous male Han:SPRD rats with PKD beginning and end of the urine collections. When deterand their normal littermates. The breeding stock was minations of plasma ammonia levels were made, blood obtained from the Polycystic Kidney Program at the samples were collected in iced syringes. Plasma and University of Kansas. All animals were allowed free acblood cells were separated immediately. Plasma proteins cess to a diet containing 24% protein and 6% fat (Teklad were precipitated with iced 10% trichloroacetic acid. 6% mouse/rat diet 7002; Harlan, Madison, WI, USA).
Supernatants were frozen, and analyses were completed In most experiments, rats were provided with either a within a few hours. An arterial blood sample (0.25 mL) solution of 55 mmol/L tripotassium citrate/67 mmol/L was also collected anaerobically for measurement of blood citric acid (KCitr) or tap water to drink beginning at one gases and pH using an IRMA series 2000 blood system month of age, and they were studied at six months of (Diametrics Medical, St. Paul, MN, USA) or model 1400 age or long-term survival was followed. In other experiblood gas electrolyte analyzer (Instrumentation Laboraments, normal rats or rats with PKD were provided with tories, Lexington, MA, USA). In some experiments, a solutions of either (1) 82.5 mmol/L diammonium citrate/ terminal blood sample (0.25 mL) was collected for 39.5 mmol/L citric acid, (2) 55 mmol/L trisodium sodium plasma calcium and phosphate determinations. citrate/67 mmol/L citric acid, or (3) 55 mmol/L K 3 citrate
The clearance studies in three-month-old rats were to drink from one month of age, and they were studied done in exactly the same way as in our previous study at three months of age. The milliequivalents of citrate on rats of this age [7] . in all citrate solutions were the same. Drinking solutions were made up in tap water.
Long-term survival
Survival studies were performed on 18 male heterozyClearance studies gous rats with PKD that drank water and on six male Before experiments, six-month-old rats were deprived heterozygous rats that drank KCitr solution starting at overnight of food but had free access to water or citrate one month of age. Three normal rats on KCitr intake since solution. They were intraperitoneally anesthetized with one month of age were sacrificed when 21 months old. the thiobarbiturate Inactin (130 mg/kg body weight; Byk Tissue collection Gulden, Konstanz, Germany). Each animal was placed on a heated table, and rectal temperature (monitored At the end of most clearance experiments, one kidney with a probe) was kept at 37ЊC. The trachea was cannu-(usually the left) was rapidly removed. Cortex and melated, and a slow flow of moistened 35% O 2 /65% N 2 was dulla were separated, and wet and dry weights (samples passed over the opening of the cannula. A femoral vein heated in an oven at 120ЊC for 16 hours) were deterwas cannulated for infusions. One milliliter of 6 g/100 mL mined. In other experiments, samples for tissue calcium fraction V bovine serum albumin in 0.9% NaCl was adwere obtained after separating kidney cortex and meministered intravenously during the surgical preparation.
dulla. Samples for tissue citrate were obtained by rapidly This was followed by a priming dose (0.2 mL/100 g body slicing off a piece of cortex, freeze-clamping it in liquid nitrogen, and then homogenizing the sample in iced 10% weight) and constant intravenous infusion at 3 mL/hour perchloric acid. The samples were centrifuged, and the Calculations supernatants were then filtered through a 10,000 molecu- [citrate]) minus urinary citrate excretion rate. Tubular kept in the same fixative solution for several days in the reabsorption was calculated from the filtered load minus refrigerator and then weighed, sliced with a razor blade, the excretion rate. Peritubular uptake of citrate was calimmersed in 0.1 mol/L cacodylate solution (pH 7.25), culated from the renal citrate consumption minus the and embedded in paraffin. Sections were stained with rate of tubular citrate reabsorption. Fractional excretion hematoxylin and eosin. The degree of cystic disease (size was calculated from the excretion rate divided by the of cysts, interstitial widening and fibrosis, presence of filtered load. Renal ammonia production was calculated inflammatory cells) was evaluated blindly using an arbifrom the RBF ϫ (renal venous blood [ammonia] Ϫ artetrary scale of 0 to 4, where 0 represents the normal rial blood [ammonia]) plus the urinary excretion rate. condition and 4 represents severe changes.
The partial pressure of cortical tissue ammonia (P NH3 ) was estimated from the renal vein total NH 4 ϩ concentraChemical analyses tion and arterial blood pH [16, 17] and this formula: Polyfructosan (a synthetic inulin) in plasma and urine P NH3 ϭ (total NH 4 ϩ ϫ 22.09)/(10 pK Ϫ pH ϫ ␣) was determined by an anthrone method [12] . PAH was determined by Bratton and Marshall's method [13] . Ciwhere the pK for NH 4 ϩ is 9.02. The pH of renal venous trate in plasma, urine, and tissue samples was determined and arterial blood are assumed to be the same, and the spectrophotometrically using a citrate lyase method solubility coefficient (␣) for ammonia is 0.91 [18] . (Boehringer Mannheim, Indianapolis, IN, USA). Recovery of citrate added to plasma averaged 99 Ϯ 6% (N ϭ Statistical methods 11). When kidney tissue was analyzed for citrate, we Data presented are means Ϯ SD. They were analyzed observed a 100 Ϯ 5% (N ϭ 25) recovery of an internal by two-way analysis of variance (ANOVA), after a precitrate standard at five minutes after adding the citrate liminary test for homogeneity of variances. Individual lyase, indicating completion of the reaction. The absorgroups were compared with the Bonferroni method. If bance readings, however, continued to drift appreciably variances were heterogeneous, the Kruskal-Wallis test with time, probably because of the presence of nicotinand Dunn's test were used to compare means. A P value amide adenine dinucleotide (NADH) oxidase activity in of less than 0.05 was considered significant. kidney cortex extracts. To correct for this "creep," we measured absorbance every 5 minutes for a total of 20 minutes after adding the citrate lyase and extrapolated RESULTS the absorbance back to time zero [14] . Ammonia was Overall function in six-month-old rats determined using a glutamate dehydrogenase-based kit
The effects of KCitr consumption in six-month-old (Boehringer Mannheim). Recovery of ammonia added normal rats and rats with PKD are summarized in Table to plasma averaged 100 Ϯ 1.4% (N ϭ 4). Phosphate in 1. The most remarkable finding is that GFR was complasma was determined by the Fiske-SubbaRow method.
pletely normal in rats with PKD that had been treated Potassium in urine and plasma and calcium in plasma, with KCitr, whereas GFR was only 37% of normal in urine, and kidney tissue were determined using an atomic rats with PKD that had consumed tap water. RBF also absorption spectrophotometer (model 951; Instrumentawas normal in the rats with PKD that had been treated tion Laboratory, Wilmington, MA, USA). Tissue samwith KCitr and was about half of normal in untreated ples were homogenized in a solution containing 4% (vol/ rats with PKD. KCitr treatment had no effect on body vol) butanol, 0.2 mol/L HCl, and 36 mmol/L LaCl 3 [15] weight or blood pressure, in agreement with our earlier using a Polytron homogenizer (Brinkmann Instruments, findings at three months of age [7] . Westbury, NY, USA). Recovery of calcium added to A comparison of water-drinking normal rats and watissue samples averaged 103 Ϯ 3% (N ϭ 9). Samples ter-drinking rats with PKD (Table 1) shows that the and standards were always prepared in the same matrix solutions.
animals with cystic disease had heavier kidneys, higher Acid-base measurements are presented in Table 2 . KCitr treatment did not prevent overall renal enlargeRats with PKD that drank tap water showed evidence ment in rats with PKD (Table 1 ). The histology of cystic of a metabolic acidosis (average plasma pH of 7.30 and bicarbonate concentration of 19 mEq/L). KCitr treatkidneys in untreated and treated rats was, however, quite ment increased blood pH and plasma bicarbonate condifferent (Fig. 1) . In tap water-drinking rats with PKD, centration in the rats with PKD, but did not significantly there was severe cystic disease, with numerous large cysts, affect these variables in normal rats. KCitr treatment interstitial widening and fibrosis, and numerous inflamsignificantly increased urine pH, by about 0.5 pH unit, matory cells; the disease score averaged 4 Ϯ 0 (N ϭ 7).
in both normal rats and rats with PKD. In KCitr-treated rats with PKD, the disease score averData on renal citrate handling in normal rats and in aged 2.6 Ϯ 0.4 (N ϭ 7), and in no case was cystic disease rats with PKD that had consumed either tap water or judged to be severe (a score of 4).
KCitr solution are presented in Table 3 . It is notable In the normal rats, KCitr treatment had no significant that in the normal rats, the arterial plasma citrate conceneffect on any of the variables measured (Table 1) or on tration and renal cortical citrate concentration were not renal histology, except for about a 10% increase in GFR, affected by increased citrate intake. In fact, KCitr intake a small increase in cortex and medulla water contents, in normal rats did not affect any of the parameters meaand a fall in hematocrit. In rats with PKD, KCitr treatsured except for expected increases in urine citrate conment overall tended to produce more normal renal funccentration, excreted citrate, and the fraction of filtered tion and structure (Table 1 and Fig. 1) .
citrate excreted in the urine. Rats with PKD that were on tap water had an elevated Long-term survival arterial plasma citrate concentration (about twice normal), diminished citrate extraction and consumption, eleKCitr treatment significantly prolonged the life of rats vated urinary citrate excretion (about 10 times normal), with PKD (Fig. 2) . The average survival time of rats that and elevated renal cortical citrate concentration when drank tap water was 288 Ϯ 39 days (N ϭ 18) . The average compared with normal rats on tap water (Table 3 ). The survival time of rats with PKD on KCitr was 506 Ϯ 33 higher rate of citrate excretion in rats with PKD is not days (N ϭ 6). The KCitr-treated animals lived well bedue to a difference in urine pH [19, 20] , since both groups yond the time all of the untreated rats with PKD had that drank tap water had urine pH values about 5.9 died (Fig. 2) . Histologic examination of kidneys from (Table 2) . A novel finding is that cortical tissue citrate old KCitr-treated rats with PKD demonstrated marked concentration is also elevated in rats with PKD, although cystic changes; hence, this treatment does not stop proto a variable extent. Figure 3 illustrates that this variabilgression of the disease. Normal plasma chemistry values ity is related to the degree of renal impairment in un-(urea, creatinine, and potassium) were found in three treated rats with PKD; tissue citrate concentration was normal rats that had consumed KCitr solution for 20 inversely related to the GFR. Increased citrate intake paradoxically led to a lower months (data not shown). arterial plasma citrate concentration and a lower concentration of citrate in cortical tissue of rats with PKD comconsumption in the normal rats, but was not affected pared with rats with PKD that drank tap water (Table  by this treatment in the rats with PKD (Table 5) . No 3). Overall, KCitr treatment of rats with PKD led to a significant differences in calcium excretion were seen in more normal pattern of renal handling of citrate. the four groups. In untreated rats, cortical tissue calcium Measurements of renal handling of ammonia are sumlevels were higher with PKD than in normals. Potassium marized in Table 4 . KCitr treatment in normal rats led citrate treatment actually raised the tissue calcium levels to significant decreases in renal ammonia production and in the cortex and medulla of normal rats and in the excretion. This may be due to two effects: (1) oxidation medulla of rats with PKD. Plasma phosphate concentraof citrate to bicarbonate and its consequent alkalinizing tion was elevated in the rats with PKD on water, but effect, and (2) inhibition of ammoniagenesis by citrate was brought closer to normal in the rats with PKD that [21] . Rats with PKD on tap water had lower rates of had been treated with KCitr. These changes in plasma production and excretion of ammonia than did normal phosphate level most likely reflect retention of phosrats on tap water. KCitr-treated rats with PKD had the phate in animals with severe renal disease (untreated same rates of production and excretion of ammonia as rats with PKD) and adequate phosphate disposal in aninormal KCitr-treated rats. mals with a normal GFR (KCitr-treated rats with PKD). Arterial ammonia concentration was lower in the rats with PKD than in normal rats when both drank tap Effects of varying drinking fluid composition water. Otherwise, there were no statistically significant Effects of varying the composition of the drinking differences in arterial ammonia concentration, renal vesolutions were determined in clearance studies on threenous ammonia concentration, or cortical P NH3 among the month-old rats. Figure 4 shows the measurements of left four groups (Table 4) .
kidney GFR from these new experiments along with Data on electrolyte handling in normal rats and in rats results from our previous study on the effects of intake with PKD that drank tap water or KCitr solution are of tap water or KCitr solution [7] . The data are normalshown in Table 5 . Surprisingly, the plasma potassium conized per 100 g body weight. None of the treatments had centration was significantly decreased in both normal rats a significant effect on body weight, and none prevented and in rats with PKD that consumed KCitr when comrenal enlargement in rats with PKD (data not shown). pared with water-drinking rats. Urinary potassium excre-
The intake of an ammonium citrate/citric acid solution tion was elevated with KCitr intake, as expected. The had no beneficial effect on GFR in rats with PKD; GFR fractional excretion of potassium (FE K ) was increased averaged 261 Ϯ 22 L/min-100 g body weight, about half with potassium intake in normal rats; in the rats with of normal, and was the same as in water-drinking rats PKD treated with KCitr, FE K was below that observed of the same age (Fig. 4) . Urine pH in rats consuming in untreated rats, most likely because of the higher GFR ammonium citrate/citric acid solution was 5.77 Ϯ 0.04 and filtered potassium load in the KCitr-treated rats.
Plasma calcium was significantly decreased by KCitr (N ϭ 4) in normal rats and 5.60 Ϯ 0.09 (N ϭ 4) in rats with PKD; intake of this solution was associated with an month of age, results in normal GFR and renal blood acidic urine pH.
flow in six-month-old animals (Table 1) . These results By contrast, substitution of sodium for potassium in extend our previous study in which a beneficial effect of the drinking solution yielded results similar to KCitr.
KCitr treatment was seen in rats treated from one to GFR in the rats with PKD, 532 Ϯ 96 L/min-100 g body three months of age [7] . Long-term KCitr therapy, started weight, was normal. Urine pH averaged 6.57 Ϯ 0.23 (N ϭ at the age of one month, prolongs the survival time of rats 4) in normal rats and 6.51 Ϯ 0.33 (N ϭ 4) in rats with with PKD (Fig. 2) . We do not know whether initiation of PKD. The renal histology of rats with PKD that had treatment at an older age, when some degree of renal consumed the sodium citrate salt (data not shown) was impairment is already present, would also be effective identical to that seen in rats of the same age that had in slowing the progression of PKD. consumed KCitr [7] . These results clearly indicate that Renal handling of citrate it is the intake of citrate or citric acid, not the provision of extra potassium in the diet, that is responsible for the We studied renal handling of citrate in an attempt to beneficial effect of KCitr.
understand why it was effective. Some of our results With the administration of K 3 citrate (potassium ciwere not expected (1) citrate concentrations in plasma, trate but no citric acid), GFR was maintained as with renal cortical tissue, and urine were all higher than norKCitr. Urine pH in the rats on K 3 citrate solution was mal in untreated rats with PKD; and (2) KCitr treatment 6.08 Ϯ 0.25 (N ϭ 2) in normal rats and 5.83 Ϯ 0.35 (N ϭ of rats with PKD led to decreases in plasma and tissue 5) in rats with PKD. Overall, the results demonstrate citrate levels, probably as a consequence of more normal that alkalinizing citrate salts prevent a decline in GFR renal function. in rats with PKD.
Plasma citrate. Two factors may explain the elevated arterial plasma citrate concentration in untreated rats DISCUSSION with PKD (Table 3) . First, renal consumption of citrate was decreased. The kidneys are the major site of citrate This study demonstrates that chronic treatment of rats which have PKD with a KCitr solution, starting at one utilization in the body [22] . Second, rats or patients with would diminish the driving force for reabsorption of filtered citrate across the luminal cell membrane and in In normal rats, plasma citrate was not affected by the level of chronic intake (Table 3) . Likewise, patients on this way could lead to increased citrate excretion [20] . Although the tenfold higher rate of citrate excretion long-term intake of potassium citrate do not show an increase in serum citrate concentration [23] .
in rats with PKD compared with normal rats is most impressive (Table 3) , it is important to note that only Tissue citrate. The elevated renal cortical tissue citrate levels in untreated rats with PKD (Table 3 and Fig. 3) 1% of the filtered load is excreted by the normal rat kidney. Fractional excretion of citrate in the untreated could be due to both an increase in intracellular citrate concentration and/or an increase in the tubular fluid or rat with PKD, 23% (Table 3) , is similar to fractional excretion of citrate in the normal human kidney, about urine citrate level. It appears to be mainly due to an increase in intracellular level, since urine concentrations 10 to 35% [20] . Excessive urinary excretion of citrate in the rat with PKD may contribute to the development of of citrate were elevated in the KCitr-treated rats and yet tissue citrate levels were not increased in these animals metabolic acidosis, since loss of citrate represents a loss of potential bicarbonate. (Table 3) .
Many factors can influence renal tissue citrate levels, Citrate consumption. Citrate is an important metabolic substrate in the kidneys, accounting for about 10% including intracellular pH, citrate production or consumption, or altered citrate transport by luminal and of their energy production [22, 24, 25] . In untreated rats with PKD, renal citrate consumption was lower than peritubular cell membrane carriers [20] . Although we cannot say why the tissue citrate level was increased in normal (Table 3) . Decreased GFR and consequent decreased tubular sodium reabsorption in cystic kidneys rats with PKD, the finding of Ogborn et al that tissue succinate levels are low suggests impaired mitochondrial probably contributes to the decreased citrate consumption, although we cannot rule out an intrinsic defect in metabolism of citrate [8] .
Citrate reabsorption and excretion. The data from the rats treated with KCitr or tap water are from our previous study [7] . GFR was preserved in the rats with PKD, which consumed solutions of KCitr (K 3 citrate ϩ citric acid), Na 3 citrate ϩ citric acid, or K 3 citrate alone, but was about half of normal in the rats that drank tap water or the (NH 4 ) 2 citrate ϩ citric acid solution.
undertaking these experiments that plasma and kidney Calcium and citrate cortex citrate concentrations are elevated in untreated
We hypothesized that citrate administration might exrats with PKD, we might have been dissuaded from adert its beneficial effect by preventing precipitation of ministering additional citrate. These surprising results bolcalcium salts and lowering tissue calcium levels. We ster our conclusion (discussed later in this article) that found, however, that KCitr treatment for five months the alkalinizing effect of citrate, rather than some other led to higher levels of calcium in the kidney, even in attribute of citrate, underlies the success of citrate therapy.
normal rats (Table 5) . Accumulation of calcium in the Data on citrate handling in patients with PKD are rat kidney with citrate intake has been observed before limited. In one study of PKD patients with nephrolithia-
[31] and appears to be a consequence of the elevated sis, an abnormally low rate of citrate excretion was seen urine pH. Deposition of calcium salts in kidney tissue in 67% of the patients, but this could be due an abnoroccurs in rats [2] and patients [26] with PKD, and can mally low urine pH [26] . Renal citrate handling by PKD lead to tissue damage and ischemia. In our study, treatpatients, as far as we know, has not been systematically ment with KCitr produced only a modest nephrocalstudied.
cinosis that did not appear to progress; normal rats on KCitr for 20 months had tissue calcium levels the same Renal handling of ammonia as in six-month-old rats (data not shown). Nevertheless, The suggestion has been made that increased intrarethe modest elevation in tissue calcium suggests that nal levels of ammonia might contribute to tubulointerstiKCitr does not ameliorate PKD by lowering tissue caltial injury in chronic renal diseases [27, 28] , including cium levels. PKD [9, 10, 29]. Torres et al reported an elevated ammoCitrate complexes calcium in the urine and inhibits nia level in human cyst fluid, but whether the fluid was the formation of renal stones [23] . Torres et al found derived from proximal or distal cysts is not clear [10] .
that giving high concentrations of another alkalinizing Also, cyst fluid total ammonia levels may not reflect agent, potassium bicarbonate (200 to 300 mmol/L), caused interstitial ammonia levels, since fluid within tubules or extensive precipitation of calcium phosphate in medulcysts is generally more acidic and ammonia is trapped lary collecting ducts [9] . Citrate may be a safer compound as NH 4 ϩ . In the present study, we detected no increase to administer than other agents that alkalinize the urine. in arterial or renal vein total ammonia concentrations or in cortical tissue P NH3 in rats with PKD (Table 4) .
Alkalinizing effect of citrate Therefore, our data do not support the hypothesis that Data in the present study strongly suggest that the elevated intrarenal ammonia levels are responsible for beneficial effect of treatment with KCitr is a consequence kidney damage in this disease.
of the citrate ion and its oxidation in the body to bicarUrinary ammonia production and excretion were bebonate (alkalinizing effect). Several observations conlow normal in cystic rat kidneys. Preuss et al demonfirm an alkalinizing effect of citrate. In rats with PKD, strated earlier that ammonia excretion was reduced in KCitr administration resulted in an arterial blood pH of patients with PKD and postulated that this was second-7.39, compared with 7.30 in water-drinking rats (Table  ary to decreased renal ammonia production, as we found 2). Urine pH was significantly more alkaline after the in the rat with PKD (Table 4) [30] . Impaired urinary administration of KCitr in both normal rats and rats excretion of ammonia could contribute to the metabolic acidosis in untreated rats with PKD (Table 2) .
with PKD (Table 2) . Renal ammonia synthesis, which is
